Javid Iqbal Dasti

Dr. Javid Iqbal Dasti

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
JDJavid Iqbal Dasti
Javid Iqbal Dasti
ATA. Malik Tareen
A. Malik Tareen
RLRaimond Lugert
Raimond Lugert
AZAndreas E. Zautner
Andreas E. Zautner
UGUwe Groß
Uwe Groß

1 August 2020 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
ZRZara Rafaque
Zara Rafaque
NANasira Abid
Nasira Abid
NLNida Liaquat
Nida Liaquat
PAPashmina Afridi
Pashmina Afridi
SSSaima Siddique
Saima Siddique
JDJavid Iqbal Dasti
Javid Iqbal Dasti
Background: Community-acquired urinary tract infections are associated with significant morbidity, and uropathogenic Escherichia coli (UPEC) alone causes 90% of urinary tract infections. This bacterium retains a diverse armament of virulence factors including fimbria, hemolysins, and siderophores production. In a post invasion scenario, formation of intracellular communities mimic biofilm-like characteristics and are linked to recurrent urinary tract infections. We investigated the effects of different frontline antibiotics on the formation, inhibition, and eradication of biofilms of virulent UPEC strains. Materials and Methods: A total of 155 UPEC strains were scrutinized for various virulence factors including gelatinase, cell surface hydrophobicity, hemagglutination, and serum bactericidal activity. Biofilm formation was confirmed by three different methods: Congo red agar, test tube, and tissue culture plate method. Biofilm inhibition and eradication assays were performed according to the standard protocols. Topographical analysis of biofilms was done by scanning electronic microscopy (SEM). Results: Out of 155 strains, 113 (73%) were strong biofilm formesr, while 37 (24%) produced biofilms at moderate level. Significant differences were observed between MICs of planktonic cells (MIC-p) and MICs of UPEC biofilms (MIC-b). Among tested frontline antibiotics, levofloxacin successfully inhibited biofilms at a concentration of 32 μg/mL, while trimethoprim eradicated biofilms at higher concentrations (512– 1024 μg/mL). Ciprofloxacin treatment at sub-MIC level significantly enhanced biofilm formation (P< 0.05). Conclusion: The majority of UPEC strains are strong biofilm formers and show higher tolerance towards frontline antibiotics in biofilm form. We observed significant inhibitory effects of levofloxacin (32 μg/mL) on UPEC biofilms, while treatment with sub-minimal concentrations of ciprofloxacin significantly enhanced biofilm formation. Out of all tested antibiotics, trimethoprim (512– 1024 μg/mL) eradicated UPEC biofilms.

1 January 2021 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
WIWajiha Imtiaz
Wajiha Imtiaz
ZSZainab Syed
Zainab Syed
ZRZara Rafaque
Zara Rafaque
SASimon Colin Andrews
Simon Colin Andrews
JDJavid Iqbal Dasti
Javid Iqbal Dasti
Background: The emergence of carbapenem-resistant and hypervirulent hypermucoviscous Klebsiella pneumoniae strains poses a significant public health challenge. We determined the MDR profiles, antibiotic resistance factors, virulence gene complement, and hypermucoviscous features of 200 clinical K. pneumoniae isolates from two major tertiary care hospitals in Islamabad and Rawalpindi, Pakistan. Methods: Susceptibility profiling and phenotypic analysis were performed according to the CLSI guidelines. Genetic determinants of antibiotic resistance and virulence were detected by PCR. Biofilm formation analysis was performed by microtiter plate assay. Results: The isolates displayed a high degree of antibiotic resistance: 36% MDR-CRKP; 38% carbapenem resistance; 55% gentamicin resistance; 53% ciprofloxacin resistance; and 59% aztreonam resistance. In particular, the level of resistance against fosfomycin (22%) and colistin (15%) is consistent with previous reports of increased resistance levels. Combined resistance to carbapenem and colistin was 7%. Genetic factors associated with colistin resistance (mcr-1 and mcr-2 genes) were detected in 12 and 9% of the isolates, respectively. Significant differences in resistance to gentamicin and levofloxacin were observed between the 200 isolates. Many of the isolates harbored genes specifying extended-spectrum and/or carbapenem-resistant β-lactamases: blaCTX-M-15 (46%), blaNDM-1 (39%), and blaOXA-48 (24%). The prevalence of the hypermucoviscous phenotype was 22% and 13% of the MDR isolates carried the rmpA gene (regulator for mucoid phenotype). Key virulence factor genes detected include those encoding: porins (ompK35 and ompK36; at 56 and 55% prevalence, respectively); adhesins (fimH, mrkD, and ycfM; at 19, 18, and 22% prevalence, respectively); and the polysaccharide regulator, bss, at 16% prevalence. Conclusion: This report highlights carbapenem-resistant K. pneumoniae (CRKP) prevalence, emerging resistance to fosfomycin, and the presence of mcr-1 and mcr-2 in colistin-resistant isolates. Further, the detection of rmpA signifies the prevalence of the hypermucoviscous trait in CRKP clinical isolates from Pakistan.

1 October 2010 in Microbiology
Verified
Journal Article
Closed access
ATA. Malik Tareen
A. Malik Tareen
JDJavid Iqbal Dasti
Javid Iqbal Dasti
AZAndreas E. Zautner
Andreas E. Zautner
UGUwe Groß
Uwe Groß
RLRaimond Lugert
Raimond Lugert
Campylobacter jejuni, an important food-borne bacterial pathogen in industrialized countries and in the developing world, is one of the major causes of bacterial diarrhoea. To identify genes which are important for the invasion of host cells by the pathogen, we screened altogether 660 clones of a transposon-generated mutant library based on the clinical C. jejuni isolate B2. Thereby, we identified a clone with a transposon insertion in gene cj0952c. As in the well-characterized C. jejuni strain NCTC 11168, the corresponding protein together with the gene product of the adjacent gene cj0951c consists of two transmembrane domains, a HAMP domain and a putative MCP domain, which together are thought to act as a chemoreceptor, designated Tlp7. In this report we show that genes cj0952c and cj0951c (i) are important for the host cell invasion of the pathogen, (ii) are not translated as one protein in C. jejuni isolate B2, contradicting the idea of a postulated read-through mechanism, (iii) affect the motility of C. jejuni, (iv) alter the chemotactic behaviour of the pathogen towards formic acid, and (v) are not related to the utilization of formic acid by formate dehydrogenase.

1 June 2007 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
PDF file
JDJavid Iqbal Dasti
Javid Iqbal Dasti
UGUwe Groß
Uwe Groß
SPSven Pohl
Sven Pohl
RLRaimond Lugert
Raimond Lugert
MWMichael Weig
Michael Weig
RSRuprecht Schmidt-Ott
Ruprecht Schmidt-Ott
The prevalence of tetracycline resistance, tetracycline MICs andtet(O) gene localization were investigated in 83Campylobacterisolates from patients suffering from acute gastroenteritis in Germany. Combined biochemical and molecular markers identified 74 isolates (89 %) asCampylobacterjejuni, including seven atypical isolates that failed to hydrolyse hippurate, and nine isolates (11 %) asCampylobactercoli. Tetracycline resistance was detected in six out of nineCampylobacter coliisolates (67 %) and 13 out of 74C. jejuniisolates (18 %). Low-level tetracycline resistance was observed forC. coli(MIC 16 μg ml−1for all strains), whereasC. jejunishowed high-level resistance (MIC >256 μg ml−1for all strains). Both low- and high-level tetracycline resistance was associated with the presence of thetet(O) gene. InC. jejuni,tet(O) was plasmid-encoded in 54 % of tetracycline-resistant isolates, whereas inC. coli,tet(O) appeared to be located on the chromosome.

12 July 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
IAIhsan Ali
Ihsan Ali
ZRZara Rafaque
Zara Rafaque
IAIbrar Ahmed
Ibrar Ahmed
FTFaiza Tariq
Faiza Tariq
SGSarah E. Graham
Sarah E. Graham
JDJavid Iqbal Dasti
Javid Iqbal Dasti
Escherichia coli lineage ST131 predominates across various spectra of extra-intestinal infections, including urinary tract infection (UTI). The distinctive resistance profile, diverse armamentarium of virulence factors and rapid global dissemination of ST131 E. coli makes it an intriguing pathogen. However, not much is known about the prevalence and genetic attributes of ST131 lineage in Pakistan. We estimated prevalence and genetic attributes of E. coli ST131 isolates causing UTI among 155 randomly selected samples. Samples were analyzed for phylogenetic grouping, O-typing and fumC/fimH typing. Isolates were further tested for the ESBL and virulence factors using PCR. Overall, 59% of the UPEC isolates belonged to the phylogenetic group B2, followed by D = 28%, B1 = 8% and A = 5%. Among 18 different Sequence-types, ST131 was the dominant lineage (n = 71; 46%) out of which 72% of the isolates were assigned to the phylogenetic group B2, while 61% adhered to the serogroup O25b. FumC/fimH typing confirmed 49% of the ST131 as H30 sub-types. In this study, significant numbers of the identified ST131 isolates were MDR and 42% showed ESBL phenotypes, out of which 37% carried bla-CTX-M-15. Moreover, different virulence factors were detected in following percentages: fimH,155(100%), iutA 86 (55%), feoB 76 (49%), papC 75 (48%), papGII 70 (45%), kpsMTII 40 (26%), papEF 37 (24%), fyuA 37 (24%), usp 22 (14%), papA 20 (13%), sfa/foc20 (13%), hlyA 18 (12%), afa 15 (10%), cdtB 11 (7%), papGI 6 (4%), papGIII 6 (4%), kpsMTIII 4 (3%) and bmaE2 (1%). Conclusively, this study provides important insight into the genetic and virulence attributes of pandemic MDR ST131 strains involved in UTIs. It also highlights higher prevalence of ST131-O25b-H30 UPEC isolates in patients, which was previously unreported from this part of globe.